rs761533681
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PM2PP3PP5_Very_Strong
The NM_003038.5(SLC1A4):c.1369C>T(p.Arg457Trp) variant causes a missense change. The variant allele was found at a frequency of 0.0000248 in 1,611,924 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Genomes: 𝑓 0.000013 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000026 ( 0 hom. )
Consequence
SLC1A4
NM_003038.5 missense
NM_003038.5 missense
Scores
12
6
1
Clinical Significance
Conservation
PhyloP100: 5.95
Genes affected
SLC1A4 (HGNC:10942): (solute carrier family 1 member 4) The protein encoded by this gene is a sodium-dependent neutral amino acid transporter for alanine, serine, cysteine, and threonine. Defects in this gene have been associated with developmental delay, microcephaly, and intellectual disability. [provided by RefSeq, Jan 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 11 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.801
PP5
Variant 2-65020916-C-T is Pathogenic according to our data. Variant chr2-65020916-C-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 372158.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-65020916-C-T is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC1A4 | NM_003038.5 | c.1369C>T | p.Arg457Trp | missense_variant | 8/8 | ENST00000234256.4 | NP_003029.2 | |
SLC1A4 | NM_001348406.2 | c.709C>T | p.Arg237Trp | missense_variant | 8/8 | NP_001335335.1 | ||
SLC1A4 | NM_001348407.2 | c.709C>T | p.Arg237Trp | missense_variant | 8/8 | NP_001335336.1 | ||
SLC1A4 | NM_001193493.2 | c.475C>T | p.Arg159Trp | missense_variant | 7/7 | NP_001180422.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC1A4 | ENST00000234256.4 | c.1369C>T | p.Arg457Trp | missense_variant | 8/8 | 1 | NM_003038.5 | ENSP00000234256 | P1 | |
LINC02245 | ENST00000653778.1 | n.513+27038G>A | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152170Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
2
AN:
152170
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000123 AC: 31AN: 251166Hom.: 0 AF XY: 0.0000810 AC XY: 11AN XY: 135722
GnomAD3 exomes
AF:
AC:
31
AN:
251166
Hom.:
AF XY:
AC XY:
11
AN XY:
135722
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000260 AC: 38AN: 1459754Hom.: 0 Cov.: 30 AF XY: 0.0000262 AC XY: 19AN XY: 726322
GnomAD4 exome
AF:
AC:
38
AN:
1459754
Hom.:
Cov.:
30
AF XY:
AC XY:
19
AN XY:
726322
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152170Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74344
GnomAD4 genome
AF:
AC:
2
AN:
152170
Hom.:
Cov.:
33
AF XY:
AC XY:
0
AN XY:
74344
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
19
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome Pathogenic:4
Pathogenic, no assertion criteria provided | literature only | OMIM | Jun 15, 2020 | - - |
Pathogenic, no assertion criteria provided | research | Lupski Lab, Baylor-Hopkins CMG, Baylor College of Medicine | - | This variant was identified in an individual with developmental delay, microcephaly, corpus callosum agenesis, hypomyelination. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Feb 16, 2023 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Aug 03, 2023 | Variant summary: SLC1A4 c.1369C>T (p.Arg457Trp) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00012 in 251166 control chromosomes (gnomAD). c.1369C>T has been reported in the literature in the homozygous state in two unrelated individuals affected with Spastic Tetraplegia-Thin Corpus Callosum-Progressive Postnatal Microcephaly Syndrome (Damseh_2015, Eldomery_2017). These data indicate that the variant is likely to be associated with disease. A functional study found that although the variant protein is expressed at a similar level as the WT protein at the plasma membrane, it has no detectable transport activity (Damseh_2015). The following publications have been ascertained in the context of this evaluation (PMID: 26041762, 28327206). Five submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as pathogenic (n=4)/likely pathogenic (n=1). Based on the evidence outlined above, the variant was classified as pathogenic. - |
not provided Pathogenic:3
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 14, 2023 | This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 457 of the SLC1A4 protein (p.Arg457Trp). This variant is present in population databases (rs761533681, gnomAD 0.05%). This missense change has been observed in individuals with spastic tetraplegia, thin corpus callosum, and progressive microcephaly (PMID: 2837306, 26041762; Invitae). ClinVar contains an entry for this variant (Variation ID: 372158). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SLC1A4 protein function. Experimental studies have shown that this missense change affects SLC1A4 function (PMID: 26041762). This variant disrupts the p.Arg457 amino acid residue in SLC1A4. Other variant(s) that disrupt this residue have been observed in individuals with SLC1A4-related conditions (PMID: 26041762, 34174466), which suggests that this may be a clinically significant amino acid residue. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Sep 10, 2024 | Published functional studies demonstrate p.R457W impairs transporter activity (PMID: 26041762); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 31763347, 26041762, Stehantsev2021[article], 33310157, 34174466, 37194416, 28327206, 2837306) - |
Likely pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Dec 01, 2023 | SLC1A4: PM2, PM3, PP3, PS4:Supporting - |
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | May 04, 2017 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Uncertain
.;D
Eigen
Pathogenic
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Pathogenic
D;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D
MetaSVM
Uncertain
D
MutationAssessor
Pathogenic
.;H
MutationTaster
Benign
D;D
PrimateAI
Pathogenic
D
PROVEAN
Pathogenic
D;D
REVEL
Pathogenic
Sift
Pathogenic
D;D
Sift4G
Uncertain
D;D
Polyphen
1.0
.;D
Vest4
MutPred
0.69
.;Gain of sheet (P = 0.0085);
MVP
MPC
1.1
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at